Niraparib significantly improved PFS and time without symptoms for women with advanced ovarian cancer who responded to ...
Gerhardt Attard, M.D., Ph.D., from University College London, and colleagues conducted a double-blind trial that evaluated combining niraparib with AAP versus placebo and AAP in mCSPC with HRR gene ...
News Medical on MSN
BRCA2 Breakthrough: New Chemoresistance Mechanism Found
One of the biggest challenges in cancer treatment is chemoresistance: tumors that initially respond well to chemotherapy become resistant over time ...
The combination of niraparib and abiraterone halves the spread of prostate cancer in men with BRCA gene mutations.
Lactate, once considered a metabolic waste product, is now recognized as a key regulator of cellular homeostasis and disease progression. In ...
One of the biggest challenges in cancer treatment is chemoresistance: Tumors that initially respond well to chemotherapy ...
Myriad Genetics (($MYGN)) announced an update on their ongoing clinical study. Myriad Genetics (MYGN) is collaborating on a clinical study titled ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
News-Medical.Net on MSN
Bowhead whale’s secret to long life revealed: precision DNA repair may hold clues for human aging
Researchers discovered that bowhead whales achieve extraordinary longevity and cancer resistance through highly efficient and ...
Updates Full-Year Guidance Financial results from Operations for third quarter 2025 versus third quarter 2024: Revenue: $3.56 billion versus $3.28 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results